Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $969417.0.

  • Kura Oncology's Gains from Investment Securities changed N/A to $969417.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $969417.0, marking a year-over-year change of. This contributed to the annual value of $703000.0 for FY2024, which is 15107.14% up from last year.
  • Kura Oncology's Gains from Investment Securities amounted to $969417.0 in Q3 2025.
  • In the past 5 years, Kura Oncology's Gains from Investment Securities ranged from a high of $1.2 million in Q1 2025 and a low of $703000.0 during Q4 2024